FDA Approval of Bosulif Adds to Toolkit of Treatment Options for Children With CML
The Food and Drug Administration (FDA) has approved Bosulif (bosutinib) for the treatment of children as young as 1 year old with newly...
Oct 10, 2023
Solving the Mystery of Long-Lasting Cancer Treatment – Scientists Reveal New Insights
Researchers from UCL, Great Ormond Street Hospital, and the Wellcome Sanger Institute have unveiled findings that shed light on why...
Aug 23, 2023
Refined Stratification and Frontline Targeted Therapies Explored in Pediatric T-ALL
The treatment of pediatric patients with T-cell acute lymphoblastic leukemia (T-ALL) has benefited from numerous advancements in...
Aug 11, 2023
Survival of children with acute lymphatic leukemia has increased to 94%, study finds
The five-year survival of all children with acute lymphatic leukemia (ALL) has continued to increase to 94%. This is evident from a...
Jul 17, 2023
BDR Pharma launches new drug for Philadelphia chromosome-positive leukemia
BDR Pharmaceuticals on Wednesday announced the launch of Nilotinib for a rare subtype of the most common childhood cancer, acute...
Jul 7, 2023
Nanomedicine research into drug delivery system a 'milestone' in the treatment of childhood cancer
Published this week in Science Translational Medicine, the research paves the way to safer and more effective treatment options for ...
May 18, 2023
Immunotherapy improves the prognosis of babies with a very aggressive leukemia
A trial with thirty patients under one year of age confirms that adding a bispecific antibody to the chemotherapy treatment increases...
May 2, 2023
Rutgers researchers show importance of low vitamin A levels as harbinger of adverse event
Scientists seeking a way to eliminate an adverse reaction to treatments for acute lymphocytic leukemia, a common childhood cancer, have...
Mar 29, 2023
Colin Seaman is the boy with the Harry Potter cells
"While developing a treatment plan, Lee introduced the family to a revolutionary treatment option for some patients with leukemia....
Jan 18, 2023
Drug Response Study of Leukemia Subtypes Advances Precise Patient-Therapy Matching
A study by researchers at St. Jude Children’s Research Hospital delving into drug response across a swath of genetic subtypes of acute...
Jan 6, 2023